Related Experiment Videos
Traditional drug therapy of hypertension in transplant recipients
1Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA.
Insights
Hypertension is common in organ transplant recipients, often linked to immunosuppressants. Managing blood pressure requires careful drug selection due to potential side effects and interactions, posing a significant challenge for physicians.
Area of Science:
- Nephrology
- Pharmacology
- Transplant Medicine
Background:
- Hypertension is a prevalent complication in organ transplant recipients.
- Immunosuppressive therapy is a major contributing factor to post-transplant hypertension.
- Managing hypertension in this population is complex due to drug interactions and side effect profiles.
Purpose of the Study:
- To review antihypertensive drug therapy in organ transplant recipients.
- To discuss the challenges in selecting appropriate medications for post-transplant hypertension.
- To highlight the role of drug interactions, particularly with cyclosporin.
Main Methods:
- Literature review of antihypertensive strategies in transplant patients.
- Analysis of common drug classes used for blood pressure control.
- Discussion of drug-drug interactions and adverse effects.
Main Results:
- Calcium channel blockers are frequently used as first-line therapy due to efficacy and beneficial interactions with cyclosporin.
- Diuretics are utilized for blood pressure and volume management.
- Other agents like ACE inhibitors and beta-blockers have also shown success in select cases.
Conclusions:
- Choosing antihypertensive drugs for transplant recipients is challenging due to frequent adverse effects and varied physician expertise.
- Optimizing blood pressure control requires careful consideration of drug efficacy, safety, and interactions.
Abstract:
Hypertension is a very common condition among recipients of transplanted organs, and is often related to immunosuppressive therapy. In many transplant centres, calcium antagonists are often used as first-line antihypertensive drug therapy, not only because of efficacy in lowering blood pressure, but also because certain members of the class have a 'beneficial' drug-drug interaction with cyclosporin, which decreases the cost of administering this very expensive immunosuppressant. Diuretics are often used both for blood pressure and volume control, and some centres have used either alpha-beta-blockers, angiotensin-converting enzyme inhibitors, and even beta-blockers with success in certain patients. The high frequency of perceived adverse effects of antihypertensive drugs in transplant recipients and the diversity of training of the specialist physicians involved in their care makes choice of traditional antihypertensive drug therapy in these patients a major challenge.